Generic drug maker Teligent files for bankruptcy protection, explores sale of the company
October 14, 2021 at 08:57 AM EDT
The company also said on Thursday its CEO resigned. Shares were down 47% in pre-market trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|